Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
16.80
-0.34 (-1.98%)
At close: Jun 27, 2025, 4:00 PM
16.91
+0.11 (0.65%)
After-hours: Jun 27, 2025, 6:54 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.64 billion as of June 27, 2025. Its market cap has decreased by -16.51% in one year.
Market Cap
1.64B
Enterprise Value
575.95M
1-Year Change
-16.51%
Ranking
Category
Stock Price
$16.80
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.64B, an increase of 399.36%. That is a compound annual growth rate of 34.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 1.64B | -17.03% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.12B |
| Johnson & Johnson | 367.34B |
| AbbVie | 331.01B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.45B |
| Abbott Laboratories | 233.10B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |